Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Lindsay NA"'
Publikováno v:
Berkeley Scientific Journal, vol 27, iss 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::3aa915f067e0c1e2905b0e32badd79b5
https://escholarship.org/uc/item/1fj2t7js
https://escholarship.org/uc/item/1fj2t7js
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 5 (2021)
Externí odkaz:
https://doaj.org/article/15f72d3265c14a23b00284e932fac9d1
Publikováno v:
Animals, Vol 8, Iss 11, p 201 (2018)
The diversity of the Canadian equine industry makes determining baseline attitudes and beliefs a challenge. Adult members of the Canadian equine industry (n = 901) participated in an online survey to report demographic information and views on the ro
Externí odkaz:
https://doaj.org/article/e8dcadfd625d4d89b30a2215bd5243e9
Autor:
Paul McGreevy, Jeannine Berger, Nic de Brauwere, Orla Doherty, Anna Harrison, Julie Fiedler, Claudia Jones, Sue McDonnell, Andrew McLean, Lindsay Nakonechny, Christine Nicol, Liane Preshaw, Peter Thomson, Vicky Tzioumis, John Webster, Sarah Wolfensohn, James Yeates, Bidda Jones
Publikováno v:
Animals, Vol 8, Iss 3, p 41 (2018)
The aim of this study was to conduct a series of paper-based exercises in order to assess the negative (adverse) welfare impacts, if any, of common interventions on domestic horses across a broad range of different contexts of equine care and trainin
Externí odkaz:
https://doaj.org/article/4333d01204834a498ac241d02391b410
Autor:
Degorce SL; Medicinal Chemistry, Oncology R&D , AstraZeneca , Cambridge Science Park , Unit 310 Darwin Building, Cambridge CB4 0WG , U.K., Anjum R; Bioscience, Oncology R&D , AstraZeneca, Boston , 35 Gatehouse Drive , Waltham , Massachusetts 02451 , United States., Bloecher A; Bioscience, Oncology R&D , AstraZeneca, Boston , 35 Gatehouse Drive , Waltham , Massachusetts 02451 , United States., Carbajo RJ; Medicinal Chemistry, Oncology R&D , AstraZeneca , Cambridge Science Park , Unit 310 Darwin Building, Cambridge CB4 0WG , U.K., Dillman KS; Bioscience, Oncology R&D , AstraZeneca, Boston , 35 Gatehouse Drive , Waltham , Massachusetts 02451 , United States., Drew L; Bioscience, Oncology R&D , AstraZeneca, Boston , 35 Gatehouse Drive , Waltham , Massachusetts 02451 , United States., Halsall CT; Medicinal Chemistry, Oncology R&D , AstraZeneca , Cambridge Science Park , Unit 310 Darwin Building, Cambridge CB4 0WG , U.K., Lenz EM; Medicinal Chemistry, Oncology R&D , AstraZeneca , Cambridge Science Park , Unit 310 Darwin Building, Cambridge CB4 0WG , U.K., Lindsay NA; Medicinal Chemistry, Oncology R&D , AstraZeneca , Cambridge Science Park , Unit 310 Darwin Building, Cambridge CB4 0WG , U.K., Mayo MF; Bioscience, Oncology R&D , AstraZeneca, Boston , 35 Gatehouse Drive , Waltham , Massachusetts 02451 , United States., Pink JH; Medicinal Chemistry, Oncology R&D , AstraZeneca , Cambridge Science Park , Unit 310 Darwin Building, Cambridge CB4 0WG , U.K., Robb GR; Medicinal Chemistry, Oncology R&D , AstraZeneca , Cambridge Science Park , Unit 310 Darwin Building, Cambridge CB4 0WG , U.K., Rosen A; Bioscience, Oncology R&D , AstraZeneca, Boston , 35 Gatehouse Drive , Waltham , Massachusetts 02451 , United States., Scott JS; Medicinal Chemistry, Oncology R&D , AstraZeneca , Cambridge Science Park , Unit 310 Darwin Building, Cambridge CB4 0WG , U.K., Xue Y; Discovery Sciences, R&D , AstraZeneca , Gothenburg SE-431 83 , Mölndal , Sweden.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2019 Nov 14; Vol. 62 (21), pp. 9918-9930. Date of Electronic Publication: 2019 Nov 01.
Autor:
Degorce SL; Medicinal Chemistry, Oncology, IMED Biotech Unit, AstraZeneca, Cambridge Science Park, Unit 310 Darwin Building, Cambridge CB4 0WG, United Kingdom. Electronic address: sebastien.degorce@astrazeneca.com., Anjum R; Bioscience, Oncology, IMED Biotech Unit, AstraZeneca, Boston, 35 Gatehouse Drive, Waltham, MA 02451, United States., Dillman KS; Bioscience, Oncology, IMED Biotech Unit, AstraZeneca, Boston, 35 Gatehouse Drive, Waltham, MA 02451, United States., Drew L; Bioscience, Oncology, IMED Biotech Unit, AstraZeneca, Boston, 35 Gatehouse Drive, Waltham, MA 02451, United States., Groombridge SD; Medicinal Chemistry, Oncology, IMED Biotech Unit, AstraZeneca, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom., Halsall CT; Medicinal Chemistry, Oncology, IMED Biotech Unit, AstraZeneca, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom., Lenz EM; Medicinal Chemistry, Oncology, IMED Biotech Unit, AstraZeneca, Cambridge Science Park, Unit 310 Darwin Building, Cambridge CB4 0WG, United Kingdom., Lindsay NA; Medicinal Chemistry, Oncology, IMED Biotech Unit, AstraZeneca, Cambridge Science Park, Unit 310 Darwin Building, Cambridge CB4 0WG, United Kingdom., Mayo MF; Bioscience, Oncology, IMED Biotech Unit, AstraZeneca, Boston, 35 Gatehouse Drive, Waltham, MA 02451, United States., Pink JH; Medicinal Chemistry, Oncology, IMED Biotech Unit, AstraZeneca, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom., Robb GR; Medicinal Chemistry, Oncology, IMED Biotech Unit, AstraZeneca, Cambridge Science Park, Unit 310 Darwin Building, Cambridge CB4 0WG, United Kingdom., Scott JS; Medicinal Chemistry, Oncology, IMED Biotech Unit, AstraZeneca, Cambridge Science Park, Unit 310 Darwin Building, Cambridge CB4 0WG, United Kingdom., Stokes S; Medicinal Chemistry, Oncology, IMED Biotech Unit, AstraZeneca, Cambridge Science Park, Unit 310 Darwin Building, Cambridge CB4 0WG, United Kingdom., Xue Y; Discovery Sciences, IMED Biotech Unit, AstraZeneca, Gothenburg SE-431 83, Mölndal, Sweden.
Publikováno v:
Bioorganic & medicinal chemistry [Bioorg Med Chem] 2018 Feb 15; Vol. 26 (4), pp. 913-924. Date of Electronic Publication: 2018 Jan 17.
Autor:
Scott JS; Oncology, IMED Biotech Unit, AstraZeneca , Cambridge CB4 0FZ, United Kingdom., Degorce SL; Oncology, IMED Biotech Unit, AstraZeneca , Cambridge CB4 0FZ, United Kingdom., Anjum R; Oncology, IMED Biotech Unit, AstraZeneca , Boston, Massachusetts 02451, United States., Culshaw J; Oncology, IMED Biotech Unit, AstraZeneca , Macclesfield SK10 4TG, United Kingdom., Davies RDM; Oncology, IMED Biotech Unit, AstraZeneca , Macclesfield SK10 4TG, United Kingdom., Davies NL; Oncology, IMED Biotech Unit, AstraZeneca , Cambridge CB4 0FZ, United Kingdom., Dillman KS; Oncology, IMED Biotech Unit, AstraZeneca , Boston, Massachusetts 02451, United States., Dowling JE; Oncology, IMED Biotech Unit, AstraZeneca , Boston, Massachusetts 02451, United States., Drew L; Oncology, IMED Biotech Unit, AstraZeneca , Boston, Massachusetts 02451, United States., Ferguson AD; Oncology, IMED Biotech Unit, AstraZeneca , Boston, Massachusetts 02451, United States., Groombridge SD; Oncology, IMED Biotech Unit, AstraZeneca , Macclesfield SK10 4TG, United Kingdom., Halsall CT; Oncology, IMED Biotech Unit, AstraZeneca , Macclesfield SK10 4TG, United Kingdom., Hudson JA; Oncology, IMED Biotech Unit, AstraZeneca , Macclesfield SK10 4TG, United Kingdom., Lamont S; Oncology, IMED Biotech Unit, AstraZeneca , Cambridge CB4 0FZ, United Kingdom., Lindsay NA; Oncology, IMED Biotech Unit, AstraZeneca , Cambridge CB4 0FZ, United Kingdom., Marden SK; Pharmaceutical Sciences, IMED Biotech Unit, AstraZeneca , Boston, Massachusetts 02451, United States., Mayo MF; Oncology, IMED Biotech Unit, AstraZeneca , Boston, Massachusetts 02451, United States., Pease JE; Oncology, IMED Biotech Unit, AstraZeneca , Cambridge CB4 0FZ, United Kingdom., Perkins DR; Oncology, IMED Biotech Unit, AstraZeneca , Macclesfield SK10 4TG, United Kingdom., Pink JH; Oncology, IMED Biotech Unit, AstraZeneca , Macclesfield SK10 4TG, United Kingdom., Robb GR; Oncology, IMED Biotech Unit, AstraZeneca , Cambridge CB4 0FZ, United Kingdom., Rosen A; Oncology, IMED Biotech Unit, AstraZeneca , Boston, Massachusetts 02451, United States., Shen M; Oncology, IMED Biotech Unit, AstraZeneca , Boston, Massachusetts 02451, United States., McWhirter C; Oncology, IMED Biotech Unit, AstraZeneca , Cambridge CB4 0FZ, United Kingdom., Wu D; Pharmaceutical Sciences, IMED Biotech Unit, AstraZeneca , Boston, Massachusetts 02451, United States.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2017 Dec 28; Vol. 60 (24), pp. 10071-10091. Date of Electronic Publication: 2017 Dec 11.
Autor:
Alagramam KN; Otolaryngology Head and Neck Surgery, University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, Ohio, USA.; Genetics and Genome Sciences, Case Western Reserve University, Cleveland, Ohio, USA.; Neurosciences, Case Western Reserve University, Cleveland, Ohio, USA., Gopal SR; Otolaryngology Head and Neck Surgery, University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, Ohio, USA., Geng R; Otolaryngology Head and Neck Surgery, University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, Ohio, USA., Chen DH; Otolaryngology Head and Neck Surgery, University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, Ohio, USA., Nemet I; Pharmacology and Cleveland Center for Membrane and Structural Biology, Case Western Reserve University, Cleveland, Ohio, USA., Lee R; Pharmacology and Cleveland Center for Membrane and Structural Biology, Case Western Reserve University, Cleveland, Ohio, USA., Tian G; Pharmacology and Cleveland Center for Membrane and Structural Biology, Case Western Reserve University, Cleveland, Ohio, USA., Miyagi M; Center for Proteomics and Bioinformatics, Case Western Reserve University, Cleveland, Ohio, USA., Malagu KF; BioFocus, a Charles River company, Chesterford Research Park, Saffron Walden, UK., Lock CJ; BioFocus, a Charles River company, Chesterford Research Park, Saffron Walden, UK., Esmieu WR; BioFocus, a Charles River company, Chesterford Research Park, Saffron Walden, UK., Owens AP; BioFocus, a Charles River company, Chesterford Research Park, Saffron Walden, UK., Lindsay NA; BioFocus, a Charles River company, Chesterford Research Park, Saffron Walden, UK., Ouwehand K; Charles River Nederland BV, Leiden, the Netherlands., Albertus F; Charles River Nederland BV, Leiden, the Netherlands., Fischer DF; Charles River Nederland BV, Leiden, the Netherlands., Bürli RW; BioFocus, a Charles River company, Chesterford Research Park, Saffron Walden, UK., MacLeod AM; BioFocus, a Charles River company, Chesterford Research Park, Saffron Walden, UK., Harte WE; Office of Translation and Innovation, Case Western Reserve University, Cleveland, Ohio, USA., Palczewski K; Pharmacology and Cleveland Center for Membrane and Structural Biology, Case Western Reserve University, Cleveland, Ohio, USA., Imanishi Y; Pharmacology and Cleveland Center for Membrane and Structural Biology, Case Western Reserve University, Cleveland, Ohio, USA.
Publikováno v:
Nature chemical biology [Nat Chem Biol] 2016 Jun; Vol. 12 (6), pp. 444-51. Date of Electronic Publication: 2016 Apr 25.